No profile data available.
Smith & Nephew plc (SNN) is a healthcare company in the bone and joint treatment equipment industry, based in Watford, United Kingdom, with about 17,000 full-time employees.
It reported revenue of $6.16 billion for fiscal year 2025, up 6.1% from fiscal year 2024, and net income of $625.00 million. Its largest business segment, Orthopaedics, Sports Medicine and Ear Nose and Throat, brought in 71% of segment revenue in fiscal year 2025. Its market capitalization was $11.40 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.
Smith & Nephew reported $6.16 billion in revenue for fiscal year 2025, up 6.1% from $5.81 billion in fiscal year 2024.
Orthopaedics, Sports Medicine and Ear Nose and Throat, with $4.37 billion or 71% of segment revenue in fiscal year 2025. Next: Advanced Wound Management (29%).
$11.40 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (bone and joint treatment equipment) include Zimmer Biomet Holdings, Inc. (ZBH), Globus Medical, Inc. (GMED), Vericel Corporation (VCEL), Alphatec Holdings, Inc. (ATEC).